Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Biotechnology and Bioengineering|August 8, 2007
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector functionQun Zhou, Srinivas Shankara, Andre Roy, et al.
The Journal of Biological Chemistry|October 29, 2010
X-ray and biochemical analysis of N370S mutant human acid β-glucosidaseRonnie R Wei, Heather Hughes, Susan Boucher, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Site-Specific Antibody Conjugation to Engineered Double Cysteine ResiduesQun Zhou, Josephine Kyazike, Ekaterina Boudanova, et al.
Plos One|May 25, 2013
A bispecific protein capable of engaging CTLA-4 and MHCII protects non-obese diabetic mice from autoimmune diabetesHongmei Zhao, Jozsef Karman, Ji-Lei Jiang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 2, 2023
Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathwayXuenan Hou, Chishun Zhou, Zuhui Liang, et al.
Mabs|June 15, 2019
Engineering an anti-CD52 antibody for enhanced deamidation stabilityHuawei Qiu, Ronnie Wei, Julie Jaworski, et al.
Mabs|June 21, 2019
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-lifeBrian C Mackness, Julie A Jaworski, Ekaterina Boudanova, et al.
Bioconjugate Chemistry|November 27, 2012
High-affinity VEGF antagonists by oligomerization of a minimal sequence VEGF-binding domainJames E Stefano, Julie Bird, Josephine Kyazike, et al.
Mabs|October 20, 2020
Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse modelsDelphine Valente, Christine Mauriac, Thorsten Schmidt, et al.
Glycobiology|March 11, 2003
A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry diseaseKaren Lee, Xiaoying Jin, Kate Zhang, et al.
Pageof 4